Shuai Wu

机构：Xuzhou Medical College, Hefei University, Second Affiliated Hospital of Xuzhou Medical College · ORCID：0000-0001-6122-6853

发表论文 40 篇 · 总被引 736 次 · h-index 10

代表论文

• Caveolin-1 ameliorates hepatic injury in non-alcoholic fatty liver disease by inhibiting ferroptosis via the NOX4/ROS/GPX4 pathway (2024 · Biochemical Pharmacology · 被引 21)
• Multifunctional Superparamagnetic Copper Iron Oxide Nanoparticles for Synergistic Cancer Therapy via Magnetic Hyperthermia, Oxidative Stress and Immune Reprogramming (2025 · Advanced Functional Materials · 被引 15)
• Chlorophyllin exerts synergistic anti-tumor effect with gemcitabine in pancreatic cancer by inducing cuproptosis (2025 · Molecular Medicine · 被引 10)
• Calcium administration appears not to benefit acute pancreatitis patients with hypocalcemia (2023 · Journal of Hepato-Biliary-Pancreatic Sciences · 被引 7)
• Elevated SREBP1 accelerates the initiation and growth of pancreatic cancer by targeting SOX9 (2025 · Biology Direct · 被引 5)
• Analysis of chemoresistance characteristics and prognostic relevance of postoperative gemcitabine adjuvant chemotherapy in pancreatic cancer (2024 · Cancer Medicine · 被引 5)